Petek Bradley J, Baggish Aaron L
Division of Cardiology, Massachusetts General Hospital, Boston, MA, USA.
Cardiovascular Performance Program, Massachusetts General Hospital, Yawkey Suite 5B, 55 Fruit Street, Boston, MA 02114, USA.
Curr Treat Options Cardiovasc Med. 2021;23(11). doi: 10.1007/s11936-021-00950-1. Epub 2021 Oct 15.
Valvular heart disease is prevalent in older athletes with primarily degenerative valvular disorders and younger athletes with congenital or genetic syndromes. Limited data exist on the risks and benefits of exercise for athletes with underlying valvular disorders, so current guidelines are primarily based upon expert consensus. This review focuses on the current data, guideline recommendations, and emerging clinical conundrums for athletes with common valvular heart conditions including aortic stenosis, bicuspid aortic valve (BAV), mitral regurgitation (MR), mitral valve prolapse (MVP), and thoracic aortic aneurysms.
瓣膜性心脏病在老年运动员中较为普遍，主要患有退行性瓣膜疾病，在年轻运动员中则主要患有先天性或遗传性综合征。关于患有潜在瓣膜疾病的运动员运动的风险和益处的数据有限，因此目前的指南主要基于专家共识。本综述重点关注患有常见瓣膜性心脏病（包括主动脉瓣狭窄、二叶式主动脉瓣（BAV）、二尖瓣反流（MR）、二尖瓣脱垂（MVP）和胸主动脉瘤）的运动员的当前数据、指南建议和新出现的临床难题。
